Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1991 | 12-1990 | |
| Cash Flows From Operating Activities | ||
| Net Income | 10,073 | -153,688 |
| Depreciation Amortization | 93,651 | 92,324 |
| Other Working Capital | 21,225 | 185,726 |
| Other Operating Activity | -15,212 | -64,481 |
| Operating Cash Flow | $109,737 | $59,881 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -95,333 | -82,894 |
| Net Acquisitions | -3,368 | -2,512 |
| Other Investing Activity | 28,985 | -1,274 |
| Investing Cash Flow | $-69,716 | $-86,680 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -47,654 | 25,470 |
| Financing Cash Flow | $-47,654 | $25,470 |
| Beginning Cash Position | 19,009 | 20,338 |
| End Cash Position | 11,376 | 19,009 |
| Net Cash Flow | $-7,633 | $-1,329 |
| Free Cash Flow | ||
| Operating Cash Flow | 109,737 | 59,881 |
| Free Cash Flow | 109,737 | 59,881 |